New Production Plant for Medical Device Components unveiled at H&T Presspart Tarragona

On the 17th September 2019 at H&T Presspart’s site in Tarragona Spain, the new production plant ‘Fenix’ was officially unveiled. The plant will manufacture injection-moulded plastic components for the pharmaceutical industry.

During the ceremony the president of the Chamber of Commerce of Tarragona, Laura Roige and GlaxoSmithKline representative Kirsty Bourner, performed a ceremonial ribbon cutting to officially launch production. Joining them was Managing Directors of H&T Presspart Tarragona Thomas Portune and Dana Shears. With this investment, H&T Presspart will continue to be a world leader of injection-moulded pharmaceutical components.

Thomas Portune spoke about the importance of the investment, stating “Our new digital and highly automated plant will be able to manufacture over 300 million of pharmaceutical components a year. This investment will allow us to continue to support our customers in improving patients’ lives with pulmonary diseases whilst maintaining our position within the global market. Today is a day of celebration and is great news for our local area and company group. A big thank you to everyone involved in the Fenix project and making it a reality”.

H&T Presspart is a world-leader of bespoke deep-drawn and injection moulded pharmaceutical components. H&T Presspart is part of the German Heitkamp and Thumann Group.